{"id":801164,"date":"2025-01-15T12:34:10","date_gmt":"2025-01-15T17:34:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/"},"modified":"2025-01-15T12:34:10","modified_gmt":"2025-01-15T17:34:10","slug":"crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/","title":{"rendered":"CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <b>Faruqi &amp; Faruqi, LLP Securities Litigation Partner <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4340568-1&amp;h=281129759&amp;u=https%3A%2F%2Fwww.faruqilaw.com%2Fattorney%2F22%2Fjames-m-wilson-jr&amp;a=James+(Josh)+Wilson\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">James (Josh) Wilson<\/span><\/a> Encourages Investors Who Suffered Losses Exceeding <span class=\"xn-money\">$75,000<\/span> In Caribou To Contact Him Directly To Discuss Their Options<\/b>\n      <\/p>\n<p>\n        <b>If you suffered losses exceeding <span class=\"xn-money\">$75,000<\/span> in <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4340568-1&amp;h=1135521746&amp;u=https%3A%2F%2Fwww.faruqilaw.com%2FCRBU&amp;a=Caribou\" target=\"_blank\" rel=\"nofollow\">Caribou<\/a> between <span class=\"xn-chron\">July 14, 2023<\/span> and <span class=\"xn-chron\">July 16, 2024<\/span><\/b>and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner <b><span class=\"xn-person\">Josh Wilson<\/span> directly <\/b>at <b>877-247-4292 <\/b>or <b>212-983-9330<\/b><b>\u00a0(Ext. 1310)<\/b>.<\/p>\n<p class=\"prntac\">\n        <b><br \/>\n          <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4340568-1&amp;h=2337816105&amp;u=https%3A%2F%2Fwww.faruqilaw.com%2FCRBU&amp;a=%5BYou+may+also+click+here+for+additional+information%5D\" target=\"_blank\" rel=\"nofollow\">[You may also click here for additional information]<\/a><br \/>\n        <\/b>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Jan. 15, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4340568-1&amp;h=4290886541&amp;u=https%3A%2F%2Fwww.faruqilaw.com%2F&amp;a=Faruqi+%26+Faruqi%2C+LLP\" target=\"_blank\" rel=\"nofollow\">Faruqi &amp; Faruqi, LLP<\/a>, a leading national securities law firm, is investigating potential claims against Caribou Biosciences, Inc. (&#8220;Caribou&#8221; or the &#8220;Company&#8221;) (NASDAQ: CRBU) and reminds investors of the <b><span class=\"xn-chron\">February 24, 2025<\/span> deadline<\/b> to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg\" title=\"Faruqi &amp; Faruqi, LLP (PRNewsfoto\/Faruqi &amp; Faruqi, LLP)\" alt=\"Faruqi &amp; Faruqi, LLP (PRNewsfoto\/Faruqi &amp; Faruqi, LLP)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Faruqi &amp; Faruqi is a leading national securities law firm with offices in <span class=\"xn-location\">New York<\/span>, <span class=\"xn-location\">Pennsylvania<\/span>, <span class=\"xn-location\">California<\/span> and <span class=\"xn-location\">Georgia<\/span>. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4340568-1&amp;h=3779794309&amp;u=https%3A%2F%2Fwww.faruqilaw.com%2F&amp;a=www.faruqilaw.com\" target=\"_blank\" rel=\"nofollow\">www.faruqilaw.com<\/a>.<\/p>\n<p>As detailed below, the complaint <span>alleges<\/span> that the Company and its executives violated federal securities laws by making false and\/or misleading statements and\/or failing to disclose that: (i) they had overstated CB-010&#8217;s safety, efficacy, and durability relative to approved autologous CAR-T cell therapies in treating patients with r\/r B-NHL and\/or LBCL, as well as CB-010&#8217;s overall clinical results and commercial prospects; (ii) Caribou was at significant risk of having insufficient cash, liquidity, and\/or other capital to fund its current business operations, including preclinical research activities associated with the allogeneic CAR-NK platform; and (iii) all the foregoing was likely to have a significant negative impact on Caribou&#8217;s business and operations.<\/p>\n<p>On <span class=\"xn-chron\">June 2, 2024<\/span>, Caribou issued a press release announcing that it had &#8220;presented updated clinical data from the ongoing ANTLER Phase 1 trial that [purportedly] indicates a single dose of CB-010 . . . has the potential to rival the safety, efficacy, and durability of approved autologous CAR-T cell therapies.&#8221;<\/p>\n<p>The next day, Evercore ISI (&#8220;Evercore&#8221;) analysts downgraded Caribou stock to &#8220;in line&#8221; and dropped their price target to <span class=\"xn-money\">$3.00<\/span> from <span class=\"xn-money\">$13.00<\/span>, stating that they were &#8220;not yet convinced&#8221; that Caribou&#8217;s therapy &#8220;will be competitive and wait on the sidelines until data in 1H 2025.&#8221; In particular, the Evercore analysts stated, inter alia, that &#8220;[o]verall, efficacy of CB-010 in 2L [second-line] LBCL is not competitive vs autologous CAR-T with lower response rate and much shorter PFS [progression-free survival]&#8221;, while also noting additional risks related to CB-010&#8217;s safety and competition.<\/p>\n<p>On this news, Caribou&#8217;s stock price fell <span class=\"xn-money\">$0.735<\/span> per share, or 25.52%, to close at <span class=\"xn-money\">$2.145<\/span> per share on <span class=\"xn-chron\">June 3, 2024<\/span>.<\/p>\n<p>Then, on <span class=\"xn-chron\">July 16, 2024<\/span>, Caribou disclosed in a filing with the United States Securities and Exchange Commission that it had &#8220;discontinued preclinical research activities associated with its allogeneic CAR-NK platform and reduced its workforce by 21 positions, or approximately 12%&#8221;, explaining that &#8220;[t]he Company is undertaking this reduction to extend its cash runway&#8221;.<\/p>\n<p>On this news, Caribou&#8217;s stock price fell <span class=\"xn-money\">$0.09<\/span> per share, or 3.3%, to close at <span class=\"xn-money\">$2.64<\/span> per share on <span class=\"xn-chron\">July 17, 2024<\/span>.<\/p>\n<p>The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.\u00a0<\/p>\n<p>Faruqi &amp; Faruqi, LLP also encourages anyone with information regarding Caribou&#8217;s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.<\/p>\n<p>To learn more about the <b>Caribou Biosciences<\/b> class action, go to <b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4340568-1&amp;h=2474860545&amp;u=https%3A%2F%2Fwww.faruqilaw.com%2FCRBU&amp;a=www.faruqilaw.com%2FCRBU\" target=\"_blank\" rel=\"nofollow\">www.faruqilaw.com\/CRBU<\/a><\/b> or <b>call<\/b>\u00a0Faruqi &amp; Faruqi partner <b><span class=\"xn-person\">Josh Wilson<\/span> directly <\/b>at <b>877-247-4292 <\/b>or <b>212-983-9330<\/b><b>\u00a0(Ext. 1310)<\/b>.<\/p>\n<p>Follow us for updates on <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4340568-1&amp;h=3936617886&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ffaruqi-%26-faruqi-llp%2F&amp;a=LinkedIn\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a>, on <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4340568-1&amp;h=2464829614&amp;u=https%3A%2F%2Fx.com%2Ffaruqilaw&amp;a=X\" target=\"_blank\" rel=\"nofollow\">X<\/a>, or on <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4340568-1&amp;h=549514483&amp;u=https%3A%2F%2Fwww.facebook.com%2FFaruqiLaw%2F&amp;a=Facebook\" target=\"_blank\" rel=\"nofollow\">Facebook<\/a>.<\/p>\n<p>Attorney Advertising. The law firm responsible for this advertisement is Faruqi &amp; Faruqi, LLP (<a href=\"\/\/10.86.178.52\/C$\/Users\/nhalloran\/AppData\/Local\/Microsoft\/Windows\/INetCache\/Content.Outlook\/6J7VE6NH\/www.faruqilaw.com\" target=\"_blank\" rel=\"nofollow\">www.faruqilaw.com<\/a>). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1959220\/Logo_11_30_2022.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1959220\/Logo_11_30_2022.jpg\" title=\"Faruqi &amp; Faruqi Logo (PRNewsfoto\/Faruqi &amp; Faruqi, LLP)\" alt=\"Faruqi &amp; Faruqi Logo (PRNewsfoto\/Faruqi &amp; Faruqi, LLP)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY96246&amp;sd=2025-01-15\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75-000-in-crbu-to-contact-him-directly-to-discuss-their-options-302351394.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75-000-in-crbu-to-contact-him-directly-to-discuss-their-options-302351394.html<\/a><\/p>\n<p>SOURCE  Faruqi &amp; Faruqi, LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY96246&amp;Transmission_Id=202501151231PR_NEWS_USPR_____NY96246&amp;DateId=20250115\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Caribou To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Caribou between July 14, 2023 and July 16, 2024and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330\u00a0(Ext. 1310). [You may also click here for additional information] NEW YORK , Jan. 15, 2025 \/PRNewswire\/ &#8212; Faruqi &amp; Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Caribou Biosciences, Inc. (&#8220;Caribou&#8221; or the &#8220;Company&#8221;) (NASDAQ: CRBU) and reminds investors of the February 24, 2025 deadline to seek the role of lead &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-801164","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Caribou To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Caribou between July 14, 2023 and July 16, 2024and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330\u00a0(Ext. 1310). [You may also click here for additional information] NEW YORK , Jan. 15, 2025 \/PRNewswire\/ &#8212; Faruqi &amp; Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Caribou Biosciences, Inc. (&#8220;Caribou&#8221; or the &#8220;Company&#8221;) (NASDAQ: CRBU) and reminds investors of the February 24, 2025 deadline to seek the role of lead &hellip; Continue reading &quot;CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-15T17:34:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options\",\"datePublished\":\"2025-01-15T17:34:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\\\/\"},\"wordCount\":751,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2457438\\\/Faruqi_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\\\/\",\"name\":\"CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2457438\\\/Faruqi_Logo.jpg\",\"datePublished\":\"2025-01-15T17:34:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2457438\\\/Faruqi_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2457438\\\/Faruqi_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/","og_locale":"en_US","og_type":"article","og_title":"CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options - Market Newsdesk","og_description":"PR Newswire Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Caribou To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Caribou between July 14, 2023 and July 16, 2024and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330\u00a0(Ext. 1310). [You may also click here for additional information] NEW YORK , Jan. 15, 2025 \/PRNewswire\/ &#8212; Faruqi &amp; Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Caribou Biosciences, Inc. (&#8220;Caribou&#8221; or the &#8220;Company&#8221;) (NASDAQ: CRBU) and reminds investors of the February 24, 2025 deadline to seek the role of lead &hellip; Continue reading \"CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-15T17:34:10+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options","datePublished":"2025-01-15T17:34:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/"},"wordCount":751,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/","name":"CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg","datePublished":"2025-01-15T17:34:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crbu-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-75000-in-crbu-to-contact-him-directly-to-discuss-their-options\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/801164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=801164"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/801164\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=801164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=801164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=801164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}